Our AI technology, DERM is now a Class IIa UKCA certified medical device. This clearance allows Skin Analytics to continue to innovate skin cancer pathways with our partners. This is the next step for Skin Analytics and our technology but it is by no means the end. We will continue to work with regulators as standards of AI in clinical pathways evolve and develop, driving towards clinical excellence.